|
Strategy reduces need for further monitoring of alefacept users.
Publication: Skin & Allergy News Publication Date: 01-SEP-05 Author: Wendling, Patrice
|
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2005 International Medical News Group
CHICAGO -- Assessing CD4 T cells at week 4 during the treatment of psoriasis with alefacept can reduce the need for further lymphocyte monitoring in some patients, Jennifer Cather, M.D., reported at the International Psoriasis Symposium sponsored by the Skin Disease Education Foundation.
The strategy could also lower costs and make alefacept therapy more convenient, she added.
Weekly CD4 counts are required by the alefacept (Amevive) package insert throughout the 12-week treatment regimen and are done as standard of...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from Skin & Allergy News |
Examine patient motivation for cosmetic surgery.(Dermatologic Surgery)
September 01, 2005
|
Pulsed dye laser effective for genital warts in men.(Dermatologic Surg...
September 01, 2005
|
Don't delay treatment of skin tumors in children.(Dermatologic Surgery...
September 01, 2005
|
Expert describes signs of deep fungal infections.(Clinical Rounds)
September 01, 2005
|
Assess ocular hemangiomas that occur with astigmatism or amblyopia.(Cl...
September 01, 2005
|
|
| Find companies classified under Pharmaceutical preparations |
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
